Medical Technologies announced today that its sensory insoles, analytics platform, and remote monitoring program will be used in a new clinical trial funded by the National Institutes of Health (NIH).
Dr. Khaled Khalaf with Vital Heart & Vein explains how the FDA-approved Rybelsus may help high-risk adults with Type 2 ...
With its new investment, Beacon plans to scale its technology and operations. It aims to accelerate neurobiomarker discovery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback